Search results

Selected filters:

North America
Strategy

Article type

Topic

Sector

Jurisdictions

955 results found for your search

Sort options
23 October 2019

IBM patent transaction puts Indian IT firm on par with rivals

Around 200 patents change hands as Big Blue selloff continues and a new HCL IP executive strikes first known deal

19 October 2019

Why the Red Hat tail will end up wagging the Big Blue dog

IBM's decision to purchase the open source powerhouse was a $34 billion bet on the future and from an IP perspective something has to give

18 October 2019

Federal Circuit <em>Tarceva</em> decision is good news for oncology patent owners

Appellate court overturns PTAB invalidation, citing uncertainties of R&D in the lucrative cancer space, as well as lack of data in prior art

15 October 2019

As PTAB settlement rate ticks up some see evidence of a maturing review system

Data shows both pre- and post-institution agreements at highest levels since 2014 and comes against backdrop of dramatic fall in new IPR filings

15 October 2019

California’s first-of-a-kind reverse payment law is a further obstacle to litigation settlements

Pharma patent litigation settlements involving the transfer of “anything of value” to the generic are now presumed anti-competitive under Golden State law

09 October 2019

Intel can’t knock out Chinese state lab’s chip patent

Invalidation efforts in both China and the United States have come up short as the US chip giant faces Chinese infringement claims

08 October 2019

New wave of company blacklistings in the US will accelerate Chinese tech’s inward turn

Eight Chinese entities – including leaders in AI, facial recognition and data forensics - added to Bureau of Industrial Security entity list

05 October 2019

The USPTO seeks AI expertise to change the rules of the game internally and externally

New role has the potential to deliver results that will enhance internal processes, improve quality, lower costs and help recover lost US influence in the international IP arena

04 October 2019

KT Corp lines up corporate patent sales with Samsung the latest customer

Korean telco has started selling patents to other operating companies in the last two years, after previous deals focused on the NPE sector

01 October 2019

Largan follows up record trade secrets win with patent campaign

Taiwanese maker of smartphone lenses is now wielding patents against not just a rival supplier but its end customer HP

30 September 2019

ITRI spin-out is plaintiff in latest genomics patent campaign

Taiwan’s Personal Genomics is going after an acquisition target of Illumina, the top player in the sequencing space

27 September 2019

Huawei’s FRAND strategy: move cases to China

The company wants to shift disputes to its home jurisdiction and persuade courts there to set a low, China-specific rate

26 September 2019

Allegations of sham pharma patent litigation are growing, but claimants have a mountain to climb

Akorn Inc’s failure to make its case against Allergan and Duke is a reminder that challenging life sciences patentees remains a tough task

21 September 2019

Huawei’s 5G spinoff bluff shows why export ban will hurt US tech firms

CEO Ren Zhengfei doesn’t think another company can build a business around Huawei’s 5G technology stack. Not only will the company's predicament not help US tech firms, it is actively hurting them

18 September 2019

Plaintiff state entities cannot claim sovereign immunity, says CAFC in precedential decision

Ruling is the latest setback for patentees in this controversial area and comes as the University of Minnesota seeks a Supreme Court review of its IPR immunity-related dispute with LSI